US 7879891
Caspase inhibitor prodrugs
granted A61PA61P1/00A61P1/04
Quick answer
US patent 7879891 (Caspase inhibitor prodrugs) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P1/16, A61P1/18